Integra LifeSciences Holdings (IART) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Integra LifeSciences Holdings (IART) has a cash flow conversion efficiency ratio of 0.009x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($9.80 Million) by net assets ($1.04 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See IART equity to assets ratio to measure how much of total assets are equity-financed.
Integra LifeSciences Holdings - Cash Flow Conversion Efficiency Trend (1995–2025)
This chart illustrates how Integra LifeSciences Holdings's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Integra LifeSciences Holdings's earnings quality to evaluate the quality of earnings relative to operating cash generation.
Integra LifeSciences Holdings Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Integra LifeSciences Holdings ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Yihai International Holding Ltd
F:YIR
|
0.024x |
|
Xinxiang Richful Lube Additive Co. Ltd
SHE:300910
|
0.050x |
|
Hunan Boyun New Materials Co Ltd
SHE:002297
|
0.037x |
|
Dongguan Eontec Co Ltd
SHE:300328
|
-0.047x |
|
Genting Plantations Bhd
KLSE:2291
|
0.031x |
|
Saha Pathana Inter-Holding PCL
BK:SPI
|
-0.003x |
|
Jiangxi Fushine Pharmaceutical Co Ltd
SHE:300497
|
0.008x |
|
Wuhan East Lake High Technology Group Co Ltd
SHG:600133
|
-0.006x |
Annual Cash Flow Conversion Efficiency for Integra LifeSciences Holdings (1995–2025)
The table below shows the annual cash flow conversion efficiency of Integra LifeSciences Holdings from 1995 to 2025. For the full company profile with market capitalisation and key ratios, see Integra LifeSciences Holdings (IART) total market value.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $1.04 Billion | $50.38 Million | 0.048x | -42.33% |
| 2024-12-31 | $1.55 Billion | $129.38 Million | 0.084x | -5.01% |
| 2023-12-31 | $1.59 Billion | $139.96 Million | 0.088x | -39.86% |
| 2022-12-31 | $1.80 Billion | $264.47 Million | 0.147x | -20.96% |
| 2021-12-31 | $1.68 Billion | $312.43 Million | 0.185x | +37.82% |
| 2020-12-31 | $1.51 Billion | $203.83 Million | 0.135x | -17.63% |
| 2019-12-31 | $1.42 Billion | $231.43 Million | 0.163x | +12.55% |
| 2018-12-31 | $1.38 Billion | $199.68 Million | 0.145x | +21.93% |
| 2017-12-31 | $962.31 Million | $114.54 Million | 0.119x | -14.14% |
| 2016-12-31 | $839.67 Million | $116.41 Million | 0.139x | +10.26% |
| 2015-12-31 | $751.44 Million | $94.48 Million | 0.126x | +11.45% |
| 2014-12-31 | $704.32 Million | $79.46 Million | 0.113x | +41.94% |
| 2013-12-31 | $670.18 Million | $53.27 Million | 0.079x | -29.91% |
| 2012-12-31 | $517.77 Million | $58.72 Million | 0.113x | -46.45% |
| 2011-12-31 | $492.64 Million | $104.33 Million | 0.212x | +0.29% |
| 2010-12-31 | $499.96 Million | $105.57 Million | 0.211x | -34.41% |
| 2009-12-31 | $444.88 Million | $143.24 Million | 0.322x | +55.33% |
| 2008-12-31 | $350.21 Million | $72.59 Million | 0.207x | +14.79% |
| 2007-12-31 | $260.43 Million | $47.03 Million | 0.181x | -25.42% |
| 2006-12-31 | $296.16 Million | $71.70 Million | 0.242x | +23.43% |
| 2005-12-31 | $289.82 Million | $56.85 Million | 0.196x | +54.92% |
| 2004-12-31 | $307.82 Million | $38.98 Million | 0.127x | -2.37% |
| 2003-12-31 | $268.53 Million | $34.83 Million | 0.130x | +0.39% |
| 2002-12-31 | $247.60 Million | $31.98 Million | 0.129x | +67.89% |
| 2001-12-31 | $204.06 Million | $15.70 Million | 0.077x | +183.43% |
| 2000-12-31 | $53.78 Million | $-4.96 Million | -0.092x | -240.18% |
| 1999-12-31 | $38.00 Million | $2.50 Million | 0.066x | +121.08% |
| 1998-12-31 | $31.40 Million | $-9.80 Million | -0.312x | -41.43% |
| 1997-12-31 | $35.80 Million | $-7.90 Million | -0.221x | -27.99% |
| 1996-12-31 | $46.40 Million | $-8.00 Million | -0.172x | +46.43% |
| 1995-12-31 | $17.40 Million | $-5.60 Million | -0.322x | -- |
About Integra LifeSciences Holdings
Integra LifeSciences Holdings Corporation manufactures and sells surgical instruments, neurosurgical, ear, nose, throat, and wound care products for use in neurosurgery, neurocritical care, and otolaryngology. It operates through Codman Specialty Surgical and Tissue Technologies segments. The company offers neurosurgery and neuro critical care products, including tissue ablation equipment, dural … Read more